Načítá se...
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
Huntington's disease (HD) is a hereditary neurodegenerative condition with no therapeutic intervention known to alter disease progression, but several trials are ongoing and biomarkers of disease progression are needed. Tau is an axonal protein, often altered in neurodegeneration, and recent st...
Uloženo v:
| Vydáno v: | J Neurochem |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053298/ https://ncbi.nlm.nih.gov/pubmed/27344050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13719 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|